BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32354328)

  • 1. Lithium induced reversible Splenial lesion in neuroleptic malignant syndrome like symptoms: two case reports.
    Ryu HU; Chung JY; Shin BS; Kang HG
    BMC Neurol; 2020 Apr; 20(1):164. PubMed ID: 32354328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible abnormality of the splenium in a bipolar patient with neuroleptic malignant syndrome.
    Achalia R; Andrade C
    Bipolar Disord; 2014 Nov; 16(7):773-5. PubMed ID: 24330276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine.
    Kaino K; Kumagai R; Furukawa S; Isono M; Muramatsu A; Fujii M; Muta Y; Asada T; Fujihara K; Yagyu H
    J Diabetes Investig; 2017 May; 8(3):392-394. PubMed ID: 27863115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Reversible Isolated Lesion in the Splenium of Corpus Callosum in a Patient with Probable Neuroleptic Malignant Syndrome -- Case Report.
    Yeh CT; Fu CH
    Acta Neurol Taiwan; 2015 Sep; 24(3)():87-91. PubMed ID: 27333832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome.
    Yang Q; Chang CC; Liu M; Yu YQ
    BMC Med Imaging; 2019 Apr; 19(1):35. PubMed ID: 31039748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible splenial lesion syndrome in neuroleptic malignant syndrome.
    Al-Edrus S; Norzaini R; Chua R; Puvanarajah S; Shuguna M; Muda S
    Biomed Imaging Interv J; 2009 Oct; 5(4):e24. PubMed ID: 21610992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible Splenial Lesion Related to Acute Lithium Intoxication in a Bipolar Patient: A Case Report.
    Goto T; Ishitobi M; Takahashi T; Higashima M; Wada Y
    J Clin Psychopharmacol; 2016 Oct; 36(5):528-9. PubMed ID: 27482969
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible splenial lesion syndrome due to oxcarbazepine withdrawal: case report and literature review.
    Jing C; Sun L; Wang Z; Chu C; Lin W
    J Int Med Res; 2018 Mar; 46(3):1277-1281. PubMed ID: 29322880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible splenial lesion syndrome associated with dengue fever: a case report.
    Sathananthasarma P; Weeratunga PN; Chang T
    BMC Res Notes; 2018 Jun; 11(1):412. PubMed ID: 29945676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible splenial lesion in neuroleptic malignant syndrome.
    Gasparini A; Poloni N; Caselli I; Ielmini M; Callegari C
    Panminerva Med; 2018 Sep; 60(3):134-135. PubMed ID: 29696960
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible splenial lesion syndrome associated with lobar pneumonia: Case report and review of literature.
    Li C; Wu X; Qi H; Cheng Y; Zhang B; Zhou H; Lv X; Liu K; Zhang HL
    Medicine (Baltimore); 2016 Sep; 95(39):e4798. PubMed ID: 27684805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcortical Structure Disruption in Diffusion Tensor Tractography of the Patient With the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity Combined With Neuroleptic Malignant Syndrome: A Case Report.
    Rhee SY; Kim HS
    Clin Neuropharmacol; 2021 Mar-Apr 01; 44(2):62-67. PubMed ID: 33560007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.
    Dosi R; Ambaliya A; Joshi H; Patell R
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24957740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically mild encephalopathy with a reversible splenial lesion and nonconvulsive status epilepticus in a schizophrenic patient with neuroleptic malignant syndrome.
    Mogi T; Toda H; Tatsuzawa Y; Fukutomi T; Soga S; Shinmoto H; Yoshino A
    Psychiatry Clin Neurosci; 2017 Mar; 71(3):212. PubMed ID: 27976828
    [No Abstract]   [Full Text] [Related]  

  • 15. A Rare Case Report of a Corpus Callosal Splenial Lesion in the Context of Atypical Neuroleptic Malignant Syndrome.
    Serdenes R; Orr S; Trio P; Chandrasekhara S; Musselman M
    J Investig Med High Impact Case Rep; 2021; 9():23247096211029751. PubMed ID: 34229456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autopsy case of cerebellar degeneration following lithium intoxication with neuroleptic malignant syndrome.
    Naramoto A; Koizumi N; Itoh N; Shigematsu H
    Acta Pathol Jpn; 1993; 43(1-2):55-8. PubMed ID: 8257473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Syndrome of mild encephalopathy with a reversible splenial corpus callosum lesion].
    Titov AV; Novicova VS; Ochkin SS; Soloveva EY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):85-87. PubMed ID: 29376989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symptoms of lithium toxicity at therapeutic levels].
    Roerdink SJ; Veth CPM; van Pamelen J; Manuputty J; Swolfs SN
    Ned Tijdschr Geneeskd; 2019 Nov; 163():. PubMed ID: 31769628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
    Kosehasanogullari SG; Akdede B; Akvardar Y; Akan M; Tunca Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1147-8. PubMed ID: 17513032
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversible Splenial Lesion Syndrome as a Challenging Casuistry.
    Tatar D; Bocian B; Świerzy K; Badura Brzoza K
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.